%0 Journal Article
%T Clinical correlation between serum YKL-40 protein level and recurrence of non-muscle invasive bladder cancer
%A Jiasheng Yan
%A Junhua Zheng
%A Min Liu
%A Peijun Shen
%J SCIE-indexed Journal
%D 2015
%R 10.3978/j.issn.2095-6959.2015.04.016
%X Bladder cancer is one of the most common malignant tumors of the urinary system. In particular, the non-muscle invasive bladder cancer (NMIBC) accounts for 70% of newly diagnosed bladder tumors, among which the stage Ta accounts for about 70%, T1 20%, and Tis 10% (1). The preferred treatment for NMIBC is transurethral resection of bladder tumor (TURBT); however, it has been reported that tumor recurrence occurs in up to 50-70% of patients within 2 years after surgery (2). The high post-operative recurrence rate of NMIBC remains a challenging issue in the clinical settings
%U http://atm.amegroups.com/article/view/8333/9331